EW Stock Analysis: Buy, Sell, or Hold?
EW - Edwards Lifesciences Corp
$94.37
2.38 (2.59%)
▲
5d:
+5.18%
30d:
+7.65%
90d:
+16.13%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Jul 23, 2026
17d
Smart Money Accumulation
None View Scanner →
Strength: 5.3/10
Get Alerted When EW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EW is fairly valued with market pricing in 2.1% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: EW is fairly valued with market pricing in 2.1% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$123.49
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$76.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EW is currently trading at $94.37, which is considered extended relative to its 30-day fair value range of $85.60 to $90.09. The stock's valuation (Forward PE: 28.0) is in line with its historical norms (26.3). At these levels, the market is pricing in 2.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EW is in a uptrend. The price is approaching resistance at $94.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EW has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EW is in a uptrend. The price is approaching resistance at $94.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: EW has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$85.60 -
$90.09
Company Quality Score
65/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
EW is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($97.31)
- NEUTRAL: Market pricing in 2.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$85.60 -
$90.09
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$85.32
Resistance Level
$94.47
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.02
Wall Street Target
$97.31
(+3.1%)
Revenue Growth (YoY)
16.7%
Earnings Growth (YoY)
8.2%
Profit Margin
17.4%
Valuation Premium vs History
+2.1% premium
PE vs Historical
28.0 vs 26.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.1%
(market-implied from PE analysis)
1-Year Target
$96.35
(+2%)
2-Year Target
$98.38
(+4%)
3-Year Target
$100.44
(+6%)
3-Yr Target (if PE normalizes)
(PE: 28→26)
PE COMPRESSION
$94.27
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.0, Growth: 12.0%)
$132.51
(+40%)
Base:
(SPY PE: 21.8, Growth: 12.0%)
$103.00
(+9%)
Bear:
(PE: 18.5, Growth: 12.0%)
$87.55
(-7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (50x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 49.72 | Current EPS (TTM): $1.85
Bull Case
$184.20
(+95%)
Analyst growth 82.0%, PE expands to 54.7
Base Case
$167.46
(+77%)
Market implied 82.0%, PE stable at 49.7
Bear Case
$62.55
(-34%)
Severe decline -20.0%, PE contracts to 42.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 10:16 PM ET
Data refreshes hourly during market hours. Next update: 11:16 PM
Data refreshes hourly during market hours. Next update: 11:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EW showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott B Ullem
SELL
13000 shares
2026-04-09
Daniel J Lippis
SELL
1019 shares
2026-04-06
Donald E Bobo Jr
SELL
22680 shares
2026-04-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
Advanced EW Option Strategies
Professional options setups generated by AI based on today's EW price and gamma walls.
